Life After GLP-1s

by Gwyn Whittaker, Owner, GreenFare Organic Cafe

About 1 in 8 Americans has tried a GLP-1 drug for weight loss, but many don’t stay on them. More than half stop within the first year, and roughly 80% discontinue within two years. Clinical trials show why: gastrointestinal side effects such as nausea, vomiting and constipation are common, along with risks including gallbladder disease and rare cases of pancreatitis. Research reported in 2024 in the Lancet Diabetes & Endocrinology found that tolerability issues, along with cost and adherence challenges, are among the leading reasons patients stop treatment.

There is, however, a clear upside. These medications reinforce a well-established truth: meaningful weight loss improves overall health. A 2023 cardiovascular outcomes trial in the New England Journal of Medicine found that weight loss associated with GLP-1 therapy significantly reduced major cardiovascular events, helping explain the drugs’ expanding use.

Still, side effects—and what happens after stopping the medication—remain important considerations.

A 2022 extension of the STEP 1 trial found that participants regained about two-thirds of their lost weight within one year after discontinuing semaglutide. Follow-up analyses in 2024 show similar trends, with many individuals regaining a substantial portion of lost weight and gradually returning toward baseline. This rebound reflects the return of appetite signals and the body’s natural tendency to restore lost weight.

Another concern is not just the regain, but what is lost during weight reduction. A 2019 study in the journal Obesity found that roughly 25% to 40% of weight lost through calorie restriction comes from lean mass, including muscle. Research in 2023 suggests similar effects among patients using GLP-1 medications. Because these drugs suppress appetite, people often consume fewer calories and less protein, increasing the likelihood that the body will break down muscle for energy.

That matters. A 2012 analysis in Proceedings of the Nutrition Society found that muscle mass declines by about 8% per decade with age. Accelerated muscle loss during weight loss can lower metabolic rate and make it easier to regain weight as fat.

For those who have stopped taking these medications, weight-bearing exercise is essential. Resistance training helps preserve and rebuild lean mass, supporting metabolism and long-term weight stability.

For those hoping to avoid medication altogether, research points to a sustainable alternative. A 2019 randomized controlled trial in Cell Metabolism found that diets higher in fiber and lower in energy density can naturally reduce calorie intake by increasing satiety. People tend to feel full sooner and eat less without deliberate restriction.

The takeaway is straightforward: Whether transitioning off GLP-1 drugs or avoiding them entirely, lasting weight management depends on preserving muscle, supporting natural satiety and building a diet centered on whole, plant-based foods.